I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pancreatic A cell | 3 studies | 34% ± 14% | |
| non-classical monocyte | 3 studies | 19% ± 3% | |
| epithelial cell | 3 studies | 25% ± 3% | |
| ciliated cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreatic A cell | 3 studies | 34% ± 14% | |
| non-classical monocyte | 3 studies | 19% ± 3% | |
| epithelial cell | 3 studies | 25% ± 3% | |
| ciliated cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 4376.62 | 89 / 89 | 100% | 72.25 | 901 / 901 |
| prostate | 100% | 3592.22 | 245 / 245 | 100% | 92.18 | 502 / 502 |
| stomach | 100% | 1788.15 | 359 / 359 | 100% | 39.92 | 286 / 286 |
| thymus | 100% | 4742.30 | 653 / 653 | 100% | 85.40 | 605 / 605 |
| brain | 100% | 2811.49 | 2641 / 2642 | 100% | 72.79 | 705 / 705 |
| ovary | 100% | 2541.00 | 180 / 180 | 100% | 53.79 | 429 / 430 |
| breast | 100% | 2011.63 | 459 / 459 | 100% | 65.90 | 1113 / 1118 |
| liver | 100% | 2091.67 | 226 / 226 | 100% | 47.82 | 404 / 406 |
| intestine | 100% | 2307.27 | 966 / 966 | 99% | 39.58 | 524 / 527 |
| skin | 99% | 1638.40 | 1799 / 1809 | 100% | 57.84 | 471 / 472 |
| pancreas | 99% | 1312.45 | 325 / 328 | 100% | 43.03 | 178 / 178 |
| lung | 100% | 2321.31 | 577 / 578 | 99% | 37.21 | 1145 / 1155 |
| bladder | 100% | 2490.10 | 21 / 21 | 98% | 36.11 | 496 / 504 |
| uterus | 100% | 2355.08 | 170 / 170 | 96% | 28.60 | 442 / 459 |
| adrenal gland | 100% | 4454.66 | 258 / 258 | 96% | 50.96 | 220 / 230 |
| esophagus | 100% | 2060.73 | 1443 / 1445 | 96% | 25.44 | 175 / 183 |
| adipose | 100% | 1985.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 37.56 | 29 / 29 |
| spleen | 100% | 2550.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 39.51 | 1 / 1 |
| blood vessel | 100% | 2839.92 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 38.38 | 79 / 80 |
| heart | 98% | 1352.26 | 840 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 1102.44 | 771 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 1680.14 | 891 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 20.62 | 43 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072675 | Biological process | osteoclast fusion |
| GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | TCTA |
| Protein name | T-cell leukemia translocation-altered gene protein (T-cell leukemia translocation-associated gene protein) |
| Synonyms | |
| Description | FUNCTION: May be required for cellular fusion during osteoclastogenesis. . |
| Accessions | P57738 ENST00000273590.4 |
